by John Conrad | Apr 3, 2026 | Policy News
Statement from John Conrad, President & CEO, iBIO “In Illinois, we’ve seen what the right environment can deliver — with recent investments from AbbVie and CSL Behring reinforcing our state’s role as a leader in biomanufacturing and innovation. And candidly, we’d...
by John Conrad | Sep 26, 2025 | Policy News
John Conrad, President and CEO of the Illinois Biotechnology Innovation Organization (iBIO) issued the following response regarding proposed 100% import duties on proprietary pharmaceutical products: “iBIO supports expanding domestic life sciences manufacturing....
